Gm19402 inhibitors are a class of chemical compounds developed to specifically target and inhibit the activity of the Gm19402 protein, a protein that, while not fully characterized, is believed to play a role in important cellular processes such as regulation, signaling, or protein-protein interactions. The inhibition of Gm19402 by these compounds is typically achieved by binding to key regions of the protein, such as its active site or other functional domains, thereby blocking its ability to interact with natural substrates or partners. This binding can result in a stable complex that prevents the protein from carrying out its normal biological functions, effectively altering the pathways in which Gm19402 is involved. The inhibitors may work through competitive inhibition, where they directly compete with natural substrates for binding sites, or through allosteric inhibition, where binding at a separate site induces conformational changes that reduce the protein's activity.
The design and development of Gm19402 inhibitors require a detailed understanding of the protein's structure and the molecular interactions that are essential for its function. Techniques such as high-throughput screening are often employed to identify potential inhibitors from large libraries of compounds. Once identified, these lead compounds are optimized through structure-activity relationship (SAR) studies, which involve modifying the chemical structure to enhance binding affinity, selectivity, and stability. The chemical structures of Gm19402 inhibitors are diverse, with functional groups that enable strong interactions with the protein, such as hydrogen bonds, hydrophobic interactions, and van der Waals forces. These interactions are crucial for ensuring that the inhibitors can effectively and specifically bind to Gm19402. Structural biology techniques like X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are commonly used to visualize the binding interactions at an atomic level, providing insights that guide further refinement of these inhibitors. Achieving high selectivity is a critical aspect of designing Gm19402 inhibitors, as it ensures that these compounds selectively target Gm19402 without affecting other proteins with similar structures or functions. This precision in targeting is essential for accurately modulating the activity of Gm19402 and for studying its role in various cellular pathways, providing valuable insights into its biological significance.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent protein kinase inhibitor, Staurosporine can modulate a wide range of protein kinases potentially affecting proteins like Gm19402. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor, Wortmannin impacts the AKT/mTOR pathway, which can alter the function of various proteins. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A specific inhibitor of MEK1/2, U0126 can affect the MAPK/ERK pathway, influencing protein activity and cellular processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Inhibits protein transport by disrupting the Golgi apparatus, potentially affecting protein processing and signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
A SERCA pump inhibitor, Thapsigargin raises cytosolic calcium levels, affecting calcium signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, SP600125 can modulate stress response pathways and protein interactions. | ||||||
LY3214996 | 1951483-29-6 | sc-507299 | 5 mg | $260.00 | ||
An ERK1/2 inhibitor, LY3214996 affects the MAPK signaling pathway, which is crucial for various protein functions. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $94.00 $348.00 | 69 | |
Inhibits BMP signaling by targeting AMPK, potentially affecting protein expression and signaling. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $116.00 $330.00 $510.00 $816.00 $1632.00 | 10 | |
Targets BCL-2, a key protein in apoptosis, which can influence cell survival pathways and protein interactions. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
A selective inhibitor of Aurora kinase A and B, affecting cell division and protein regulation. | ||||||